By Dawood Fakhir ( October 22, 2025, 3:13 PM BST) -- Global biopharmaceutical company Ipsen said Wednesday that it will acquire a biotechnology company, ImCheck Therapeutics, from a consortium of French, European and U.S. investors for up to €1 billion ($1.16 billion) to boost the portfolio of its cancer treatments....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.